Bayer Intellectual Property Gmbh

Bayer Schering Pharma Ag

Bayer Healthcare Aktiengesellschaft

Aicuris Gmbh + Co. Kg.

Joachim Krüger

Martin Hendrix

Christina Erb

Joachim Luithle

Christoph Methfessel

Rudy Schreiber

Welf-Burkhard Wiese

Frank-Gerhard Böβ

Holger Paulsen

Adrian Tersteegen

Susanne Röhrig

Hans-Christian Militzer

Christoph Gerdes

Stefan Heitmeier

Mark Jean Gnoth

Marcus Bauser

Ulrich Rester

Swen Allerheiligen

Georges Von Degenfeld

Dirk Heimbach

Frank-Gerhard Böss

Mathias Berwe

Walter Kroh

Jorma Haβfeld

Oliver Kuhn

Elke Dittrich-Wengenroth

Jörg Gries

Uwe Saatmann

Käthe Gooβen

Frank-Gerhard Böß

Kai Lovis

Danja Groβbach

Danja Grossbach

Käthe Goossen

The invention relates to novel heteroaryl carboxamides, processes for their preparation, and their use for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.

Heteroaryl carboxamides

The invention relates to novel heteroaryl carboxamides, a process for their preparation, and pharmaceutical compositions containing them. These materials are useful for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.

The invention relates to a novel process for the preparation of pan-CDK inhibitors of the formula (I), and intermediates of the preparation. 

Process for preparing pan-CDK inhibitors of the formula (I), and intermediates in the preparation

The present invention relates to a process for the preparation of substituted 3-(2-hydroxyethyl)-1-[4-nitrophenyl]pyridin-2(1H)-ones which serve as important intermediate compounds for producing drugs.

Method for producing substituted pyridin-2-one

The invention relates to novel substituted oxazolidinones, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular of thromboembolic disorders.

Substituted oxazolidinones and their use

The present invention relates to a process for the preparation of dihydroquinazolines, for example {8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4-yl}acetic acid, which are used as antiviral agents in the production of medicaments.

Process for the preparation of dihydroquinazolines

Heteroaryl carboxylic acid amides

Growing community of inventors

Düsseldorf, Germany

Joachim Krüger